CA2831889C - Toner compositions - Google Patents

Toner compositions Download PDF

Info

Publication number
CA2831889C
CA2831889C CA2831889A CA2831889A CA2831889C CA 2831889 C CA2831889 C CA 2831889C CA 2831889 A CA2831889 A CA 2831889A CA 2831889 A CA2831889 A CA 2831889A CA 2831889 C CA2831889 C CA 2831889C
Authority
CA
Canada
Prior art keywords
toner
charge control
percent
control agent
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2831889A
Other languages
French (fr)
Other versions
CA2831889A1 (en
Inventor
Maura A. Sweeney
Robert D. Bayley
Grazyna E. Kmiecik-Lawrynowicz
Brian S. Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xerox Corp
Original Assignee
Xerox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xerox Corp filed Critical Xerox Corp
Publication of CA2831889A1 publication Critical patent/CA2831889A1/en
Application granted granted Critical
Publication of CA2831889C publication Critical patent/CA2831889C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/097Plasticisers; Charge controlling agents
    • G03G9/09708Inorganic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/0802Preparation methods
    • G03G9/0804Preparation methods whereby the components are brought together in a liquid dispersing medium
    • G03G9/0806Preparation methods whereby the components are brought together in a liquid dispersing medium whereby chemical synthesis of at least one of the toner components takes place
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/087Binders for toner particles
    • G03G9/08702Binders for toner particles comprising macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • G03G9/08706Polymers of alkenyl-aromatic compounds
    • G03G9/08708Copolymers of styrene
    • G03G9/08711Copolymers of styrene with esters of acrylic or methacrylic acid
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/093Encapsulated toner particles
    • G03G9/0935Encapsulated toner particles specified by the core material
    • G03G9/09357Macromolecular compounds
    • G03G9/09371Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/093Encapsulated toner particles
    • G03G9/09392Preparation thereof
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/097Plasticisers; Charge controlling agents
    • G03G9/09783Organo-metallic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/0802Preparation methods
    • G03G9/0804Preparation methods whereby the components are brought together in a liquid dispersing medium
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G9/00Developers
    • G03G9/08Developers with toner particles
    • G03G9/0825Developers with toner particles characterised by their structure; characterised by non-homogenuous distribution of components

Abstract

A toner having charge control agents which impart excellent triboelectric charging characteristics. In embodiments, the toner particles are made by a process in which the toner particles are made without a shell which provides homogenous distribution of the charge control agents, providing a toner with higher charge and better environmental stability

Description

TONER COMPOSITIONS
BACKGROUND
[0001] The present disclosure relates to toners and processes useful in providing toners suitable for electrophotographic apparatuses, including apparatuses such as digital, image-on-image, and similar apparatuses. In particular, the present embodiments are directed to a process for making toners that increases the charge of the toner particles, and toners made from the same.
[0002] Numerous processes are within the purview of those skilled in the art for the preparation of toners. Emulsion aggregation (EA) is one such method. These toners are within the purview of those skilled in the art and toners may be formed by aggregating a colorant with a latex polymer formed by emulsion polymerization.
For example, U.S. Patent No. 5,853,943 is directed to a semi-continuous emulsion polymerization process for preparing a latex by first forming a seed polymer.
Other examples of emulsion/aggregation/coalescing processes for the preparation of toners are illustrated in U.S. Patent Nos. 5,403,693, 5,418,108, 5,364,729, and 5,346,797.
Other processes are disclosed in U.S. Patent Nos. 5,527,658, 5,585,215, 5,650,255, 5,650,256 and 5,501,935.
[0003] Toner systems normally fall into two classes: two component systems, in which the developer material includes magnetic carrier granules having toner particles adhering triboelectrically thereto; and single component systems (SDC), which may use only toner. Placing charge on the particles, to enable movement and development of images via electric fields, is most often accomplished with triboelectricity.
Triboelectric charging may occur either by mixing the toner with larger carrier beads in a two component development system or by rubbing the toner between a blade and donor roll in a single component system.
[0004] Charge control agents (CCA) may be utilized to enhance triboelectric charging. Charge control agents may include organic salts or complexes of large organic molecules. Such agents may be applied to toner particle surfaces by a blending process. Such charge control agents may be used in small amounts of from about 0.01 weight percent to about 5 weight percent of the toner to control both the polarity of charge on a toner and the distribution of charge on a toner.
Although the amount of charge control agents may be small compared to other components of a toner, charge control agents may be important for triboelectric charging properties of a toner. These triboelectric charging properties, in turn, may impact imaging speed and quality, as well as allow for extended life performance. Examples of charge control agents include those found in EP Patent Application No. 1426830, U.S.
Patent No. 6,652,634, EP Patent Application No. 1383011, U.S. Patent Application Publication No. 2004/0002014, U.S. Patent Application Publication No.
2003/0191263, U.S. Patent No. 6,221,550, and U.S. Patent No. 6,165,668.
100051 One issue that may arise with charge control agents is that they are difficult to incorporate into emulsion aggregation toners. Generally, during incorporation some PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 charging properties are lost. Namely, the charging property is no longer evident when the additive package is added to the particle, causing a drastic decrease in charge and thus ultimately impacting life performance of the toner.
100061 Moreover, current toner formulations show that charging is zone specific, performing with stability in B zone and J Zone but worsening in A Zone.
Through the addition of a shell to the toner particle, passivation of the pigments is possible but if a charge control agent is added to the core, shell or both, the charge control agent tends to create inhomogeneity of the charging. This is due to the fact that the addition of charge control agents in the shell tends to cause non-homogenous distribution of the charge control agent, and thus, leads to inhomogeneity of the charging. Compounding the problem is the fact that high amounts of residual surfactant also contribute to zone variability in the charging. Because most emulsion aggregate toner is made with nano-sized pigment, wax and latex, all of these substituents must be dispersed using high surfactant levels. An issue with this method is that too much surfactant causes issues with zone charging from J zone to A zone to B zone.
100071 Thus, improved methods for producing toner, which permit excellent control of the charging of toner particles, remain desirable.
SUMMARY
[0008] According to aspects illustrated herein, there is provided a toner comprising shell-less toner particles comprising a core portion comprising a resin, wax and colorant, and a charge control agent distributed homogenously throughout the core portion.
[0009] In another embodiment, there is provided a process for a toner comprising } 00090640 v 1 } - 3 -shell-less toner particles comprising a core portion comprising a resin, wax and colorant, a charge control agent distributed homogenously throughout the core portion, and a residual surfactant on a surface of the core portion.
[0010] In yet further embodiments, there is provided a process for producing toner comprising: adding and mixing a colorant, a wax, and a charge control agent to an emulsion comprising at least one resin to form toner particles; aggregating the particles to form aggregated particles; and coalescing the aggregated particles to form shell-less toner particles comprising a core portion comprising a resin, wax and colorant, and a charge control agent distributed homogeneously throughout the core portion.
[0010a] In an aspect, the charge control agent is present in an amount of from about 0.01 to about 15 percent by weight of the total weight of the toner particle.
[0010b] In an aspect, a bulk level of the charge control agent is from about 0.1 to about 50 percent by weight of the total weight of the toner particle.
[0010c] In an aspect, the bulk level of the charge control agent is increased from about 5 to about 30 percent as compared to a bulk level of a toner particle prepared with the shell.
[0010d] In an aspect, the surface level of the charge control agent is increased from about 0.1 to about 15 percent as compared to a bulk level of a toner particle prepared with the shell.
[0010e] In accordance with another aspect, there is provided a toner comprising shell-less toner particles comprising a core portion comprising a resin, wax and colorant, and a charge control agent distributed homogenously throughout the core portion, wherein a bulk level of the charge control agent in the core portion is from about 0.1 to about percent by weight of the total weight of the toner particle and a surface level of the charge control agent on the core portion is from about 0.01 to about 10 percent by weight of the total weight of the toner particle.
[0010f] In accordance with another aspect, there is provided a toner comprising shell-less toner particles comprising a core portion comprising a resin, wax and colorant, a charge control agent distributed homogenously throughout the core portion, and a residual surfactant on a surface of the core portion, wherein an amount of surfactant present in the toner particle is from about 20 to about 2500 ppm of the toner particle.
[0010g] In accordance with another aspect, there is provided a process for producing toner comprising:
adding and mixing a colorant, a wax, and a charge control agent to an emulsion comprising at least one resin to form toner particles;
aggregating the particles to form aggregated particles; and coalescing the aggregated particles to form shell-less toner particles comprising a core portion comprising a resin, wax and colorant, and a charge control agent distributed homogeneously throughout the core portion, wherein a bulk level of the charge control agent in the core portion is from about 0.1 to about 50 percent by weight of the total weight of the toner particle and a surface level of the charge control agent on the core portion is from about 0.01 to about 10 percent by weight of the total weight of the toner particle.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 is a schematic diagram illustrating the process of producing a shell-less toner according to the present embodiments.
DETAILED DESCRIPTION OF EMBODIMENTS
- 4a -100121 The present disclosure provides toners and processes for the preparation of toner particles having excellent charging characteristics. It has been discovered that, by making an emulsion aggregate toner without the shell, more charge control agent is present in the toner and at the surface for charging stability throughout all zones.
Furthermore, by adjusting the emulsion aggregation process and increasing the amount of charge control agent incorporated into the core-type particle (without the shell), more charge control agent is exposed and available and less surfactant is present to impact the higher humidity zones. As a result, the present embodiments provide an improved process for incorporating polymerized internal charge control agents and reducing the - 4b -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 surfactant level in toners, especially emulsion aggregate toners, to provide higher charge and improved environmental charging stability.
100131 The present embodiments thus provide a toner formulation and a process for producing the same in which a charge control agent is incorporated into a toner particle without a shell. By eliminating the shell formation step, and then washing, the charge control agent is better incorporated into the particle core and the surfactants are more readily removed. It is believed that the shell may encapsulate the surfactants and prevent their removal during washing.
[0014] In embodiments, toners of the present disclosure may be prepared by combining a latex polymer with an optional colorant, an optional wax, and other optional additives. In embodiments, the CCA is added to a latex, colorant, wax, and other additives to incorporate the CCA within the toner particles. While the latex polymer may be prepared by any method within the purview of those skilled in the art, in embodiments the latex polymer may be prepared by emulsion polymerization methods, including semi-continuous emulsion polymerization, and the toner may include emulsion aggregation toners. Emulsion aggregation involves aggregation of submicron latex, waxand pigment particles into toner size particles, where the growth in average particle size is, for example, in embodiments from about 0.1 micron to about 15 microns, or from about 1.5 to about 10 microns, or from about 3.5 to about 8 microns.
[0015] As shown in Figure 1, the process of the present embodiments comprises combining and initial mixing of a charge control agent, polymeric resin, wax and pigment
5, followed by the aggregation of these components 10, and then coalescence 15 to { 00090640 v 1} - 5 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 achieve the proper toner shape without the shell to hinder charging of the charge control latex.
[0016] While the toner may be of any type, in specific embodiments, the toner is an emulsion aggregation toner. It was demonstrated that formulation of the toner particle was optimized using the emulsion/aggregation process. The toner may have a particle shape including, circular, needle-like, potato, rasberry and mixtures thereof In embodiments, the toner particles may have a circularity of from about 0.940 to about 0.999, or from about 0.950 to about 0.995, or from about 0.960 to about 0.990.
[0017] Charge Control Agents [0018] Suitable charge control agents which may be utilized include, in embodiments, metal complexes of alkyl derivatives of acids such as salicylic acid, other acids such as dicarboxylic acid derivatives, benzoic acid, oxynaphthoic acid, sulfonic acids, other complexes such as polyhydroxyalkanoate quaternary phosphonium trihalozincate, metal complexes of dimethyl sulfoxide, combinations thereof, and the like. Metals utilized in forming such complexes include, but are not limited to, zinc, manganese, iron, calcium, zirconium, aluminum, chromium, combinations thereof, and the like. Alkyl groups which may be utilized in forming derivatives of salicylic acid include, but are not limited to, methyl, butyl, t-butyl, propyl, hexyl, combinations thereof and the like.
Examples of such charge control agents include those commercially available as BONTRON E-and BONTRON E-88 (commercially available from Orient Chemical). BONTRON E-84 is a zinc complex of 3,5-di-tert-butylsalicylic acid in powder form.

is a mixture of hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoate] and 3,5-di-tert-butylsalicylic acid. Other suitable CCAs include the calcium complex of 3,5-di-tert-{00090640 v1} - 6 -butylsalicylic acid, a zirconium complex of 3,5-di-tert-butylsalicylic acid, and an aluminum complex of 3,5-di-tert-butylsalicylic acid, as disclosed in U.S.
Patent Nos.
5,223,368 and 5,324,613, combinations thereof, and the like.
[0019] In specific embodiments, the charge control agent is a zinc or aluminum-type salicyclic acid polymeric charge control agent, such as for example, zinc and aluminum 3,5-ditertiary butyl salicylic acid. In embodiments, the charge control agent is present in an amount of from about 0.05 to about 10 percent, or of from about 0.1 to about 5 percent, or of from about 0.15 to about 3 percent by weight of the total weight of the toner particle. In embodiments, the resulting toner has increased bulk and surface levels of the charge control agent and lower levels of surfactant.
The toner also exhibits higher charge level in A zone. For example, the toner may have a triboelectric charge of from about -10 to about 80 uC/gm or from about -15 to about -60 uC/gm or from about -20 to about -40 uC/gm in A zone.
[0020] Specifically, the bulk level of the charge control agent is from about 0.05 to about 15 percent, or of from about 0.1 to about 10 percent, or of from about 0.2 to about 5 percent by weight of the total weight of the toner particle. As used herein, the "bulk level" is defined as the level of CCA throughout the particle, both core and shell.
Such amounts are an increase of from about 0.1 to about 20 percent, or of from about 0.25 to about 15 percent, or of from about 0.75 to about 10 percent as compared to the bulk level of a toner particle prepared with the shell. The surface level of the charge control agent is from about 0.001 to about 10 percent, or of from about 0.01 to about 5 percent, or of from about 0.1 to about 2.5 percent by weight of the total weight of the toner particle. As used PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 herein, the "surface level" is defined as the level of CCA measured on the toner particle surface and not in the bulk toner. Such amounts are an increase of from about 0.01 to about 10 percent, or of from about 0.1 to about 5 percent, or of from about 0.5 to about 2.5 percent as compared to the surface level of a toner particle prepared with the shell.
[0021] In the present embodiments, the charge control agent is spread or distributed homogenously throughout the toner particle, including the core portion. As used herein, "homogenous" means uniform composition throughout. Thus, in the present embodiments, the charge control agent is distributed uniformly throughout the toner particles, including the core portion. In embodiments, the homogeneity of the charge control distribution is from about 1 to about 98 percent, or from about 5 to about 78 percent, or from about 10 to about 68 percent, with 100% indicating complete homogeneity. The present embodiments achieve from about 0.1 to about 99 percent, or from about 10 to about 94 percent, or from about 20 to about 90 percent greater homogeneity than a toner particle prepared with the shell.
Resin [0022] Any monomer suitable for preparing a latex for use in a toner may be utilized. As noted above, in embodiments the toner may be produced by emulsion aggregation.

Suitable monomers useful in forming a latex polymer emulsion, and thus the resulting latex particles in the latex emulsion, include, but are not limited to, styrenes, acrylates, methacrylates, butadienes, isoprenes, acrylic acids, methacrylic acids, acrylonitriles, combinations thereof, and the like.
[0023] In embodiments, the latex polymer may include at least one polymer. In embodiments, at least one may be from about one to about twenty and, in embodiments, PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 from about three to about ten. Exemplary polymers include styrene acrylates, styrene butadienes, styrene methacrylates, and more specifically, poly(styrene-alkyl acrylate), poly(styrene-1,3-diene), poly(styrene-alkyl methacrylate), poly (styrene-alkyl acrylate-acrylic acid), poly(styrene-1,3-diene-acrylic acid), poly (styrene-alkyl methacrylate-acrylic acid), poly(alkyl methacrylate-alkyl acrylate), poly(alkyl methacrylate-aryl acrylate), poly(aryl methacrylate-alkyl acrylate), poly(alkyl methacrylate-acrylic acid), poly(styrene-alkyl acrylate-acrylonitrile-acrylic acid), poly (styrene-1,3-diene-acrylonitrile-acrylic acid), poly(alkyl acrylate-acrylonitrile-acrylic acid), poly(styrene-butadiene), poly(methylstyrene-butadiene), poly(methyl methacrylate-butadiene), poly(ethyl methacrylate-butadiene), poly(propyl methacrylate-butadiene), poly(butyl methacrylate-butadiene), poly(methyl acrylate-butadiene), poly(ethyl acrylate-butadiene), poly(propyl acrylate-butadiene), poly(butyl acrylate-butadiene), poly(styrene-isoprene), poly(methylstyrene-isoprene), poly (methyl methacrylate-isoprene), poly(ethyl methacrylate-isoprene), poly(propyl methacrylate-isoprene), poly(butyl methacrylate-isoprene), poly(methyl acrylate-isoprene), poly(ethyl acrylate-isoprene), poly(propyl acrylate-isoprene), poly(butyl acrylate-isoprene), poly(styrene-propyl acrylate), poly(styrene-butyl acrylate), poly (styrene-butadiene-acrylic acid), poly(styrene-butadiene-methacrylic acid), poly (styrene-butadiene-acrylonitrile-acrylic acid), poly(styrene-butyl acrylate-acrylic acid), poly(styrene-butyl acrylate-methacrylic acid), poly(styrene-butyl acrylate-acrylononitrile), poly(styrene-butyl acrylate-acrylonitrile-acrylic acid), poly(styrene-butadiene), poly(styrene-isoprene), poly(styrene-butyl methacrylate), poly(styrene-butyl acrylate-acrylic acid), poly(styrene-butyl methacrylate-acrylic acid), poly(butyl methacrylate-butyl acrylate), poly(butyl methacrylate-acrylic {00090640 v1} - 9 -acid), poly(acrylonitrile-butyl acrylate-acrylic acid), and combinations thereof. The polymers may be block, random, or alternating copolymers.
[0024] In addition, polyester resins may be used as the latex polymer.
Suitable polyesters which may be used include those obtained from the reaction products of bisphenol A and propylene oxide or propylene carbonate, as well as the polyesters obtained by reacting those reaction products with fumaric acid (as disclosed in U.S.
Patent No. 5,227,460), and branched polyester resins resulting from the reaction of dimethylterephthalate with 1,3-butanediol, 1,2-propanediol, and pentaerythritol. In embodiments, combinations of polyester resins, including amorphous polyester resins and crystalline polyester resins, may be utilized. Examples of such polyesters include those disclosed in U.S. Patent Application Publication No. 2009/0047593.
[0025] In embodiments, a poly(styrene-butyl acrylate) may be utilized as the latex polymer. The glass transition temperature of this latex, which in embodiments may be used to form a toner of the present disclosure, may be from about 35 C to about 75 C, in embodiments from about 40 C to about 70 C, in embodiments from about 45 C to about 65 C.
[0026] In embodiments, the resin used to form a toner may have a weight average molecular weight (Mw) of from about 25 kpse to about 75 kpse, in embodiments from about 30 kpse to about 55 kpse, in other embodiments from about 35 kpse to about 55 kpse. The resin used to form a toner may have a number average molecular weight (Mn) of from about I kpse to about 30kpse, in embodiments from about 2 kpse to about 20 PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 kpse, in other embodiments from about 3 kpse to about 15 kpse. The polydispersity of the resin, i.e., Mw/Mn, may thus be of from about 0.5 to about 15, in embodiments from about 0.75 to about 10, in other embodiments from about 1 to about 5. The amount resin present in the toner may thus be of from about 50% wt/wt to about 90% wt/wt, in further embodiments from about 65% wt/wt to about 85% wt/wt, in other embodiments from about 70% wt/wt to about 80% wt/wt.
Surfactants [0027] In embodiments, the latex may be prepared in an aqueous phase containing a surfactant or co-surfactant. Surfactants which may be utilized with the polymer to form a latex dispersion can be ionic or nonionic surfactants, or combinations thereof, in an amount of from about 0.01 to about 15 weight percent of the solids, in embodiments of from about 0.1 to about 10 weight percent of the solids, in embodiments from about 1 to about 7.5 weight percent solids.
[0028] Anionic surfactants which may be utilized include sulfates and sulfonates, sodium dodecylsulfate (SDS), sodium dodecylbenzene sulfonate, sodium dodecylnaphthalene sulfate, dialkyl benzenealkyl sulfates and sulfonates, acids such as abietic acid available from Aldrich, NEOGEN RTM, NEOGEN SCTM obtained from Daiichi Kogyo Seiyaku Co., Ltd., combinations thereof, and the like.
[0029] Examples of cationic surfactants include, but are not limited to, ammoniums, for example, alkylbenzyl dimethyl ammonium chloride, dialkyl benzenealkyl ammonium chloride, lauryl trimethyl ammonium chloride, alkylbenzyl methyl ammonium chloride, alkyl benzyl dimethyl ammonium bromide, benzalkonium chloride, C12, C15, C17 trimethyl ammonium bromides, combinations thereof, and the like. Other cationic {00090640v1} - 11 -PATENT APPLICATION
Attorney Docket No 20120439CA01-418295 surfactants include cetyl pyridinium bromide, halide salts of quaternized polyoxyethylalkylamines, dodecylbenzyl triethyl ammonium chloride, MIRAPOL and ALKAQUAT available from Alkaril Chemical Company, SANISOL (benzalkonium chloride), available from Kao Chemicals, combinations thereof, and the like.
In embodiments a suitable cationic surfactant includes SANISOL B-50 available from Kao Corp., which is primarily a benzyl dimethyl alkonium chloride.
[0030] Examples of nonionic surfactants include, but are not limited to, alcohols, acids and ethers, for example, polyvinyl alcohol, polyacrylic acid, methalose, methyl cellulose, ethyl cellulose, propyl cellulose, hydroxyl ethyl cellulose, carboxy methyl cellulose, polyoxyethylene cetyl ether, polyoxyethylene lauryl ether, polyoxyethylene octyl ether, polyoxyethylene octylphenyl ether, polyoxyethylene oleyl ether, polyoxyethylene sorbitan monolaurate, polyoxyethylene stearyl ether, polyoxyethylene nonylphenyl ether, dialkylphenoxy poly(ethyleneoxy) ethanol, combinations thereof, and the like.
In embodiments commercially available surfactants from Rhone-Poulenc such as IGEPAL
CA-21OTM, IGEPAL CA52OTM, IGEPAL CA-720TM, IGEPAL CO89OTM, IGEPAL CO-720TM, IGEPAL CO29OTM, IGEPAL CA-21OTM, ANTAROX 890TM and ANTAROX
897TM can be utilized.
[0031] In embodiments, the amount of surfactant present in the toner particle is reduced.
Specifically, the amount of surfactant present in the toner particle is from about 1 to about 70 percent, or of from about 3 to about 60 percent, or of from about 5 to about 50 percent by weight of the total weight of the toner particle. Such amounts are a decrease of from about 30 to about 98 percent, or of from about 40 to about 94 percent, or of from {00090640 v 1 } - 12 -, PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 about 50 to about 90 percent as compared to the amount of surfactants present in a toner particle prepared with the shell.
[0032] The choice of particular surfactants or combinations thereof, as well as the amounts of each to be used, are within the purview of those skilled in the art.
Initiators [0033] In embodiments initiators may be added for formation of the latex polymer.
Examples of suitable initiators include water soluble initiators, such as ammonium persulfate, sodium persulfate and potassium persulfate, and organic soluble initiators including organic peroxides and azo compounds including Vazo peroxides, such as VAZO 64TM, 2-methyl 2-2' -azobis propanenitrile, VAZO 88TM, 2-2' - azobis isobutyramide dehydrate, and combinations thereof. Other water-soluble initiators which may be utilized include azoamidine compounds, for example 2,2'-azobis(2-methyl-N-phenylpropionamidine) dihydrochloride, 2,2'-azobis[N-(4-chloropheny1)-2-methylpropionamidine] di-hydrochloride, 2,2'-azobis[N-(4-hydroxypheny1)-2-methyl-propionamidine]dihydrochloride, 2,2'-azobis[N-(4-amino-phenyl)-2-methylpropionamidine]tetrahydrochloride, 2,2'-azobis[2-methyl-N(phenylmethyl)propionamidine]dihydrochloride, 2,2'-azobis[2-methyl-N-2-propenylpropionamidine]dihydrochloride, 2,2'-azobis[N-(2-hydroxy-ethy1)2-methylpropionamidine}dihydrochloride, 2,2'-azobis[2(5-methy1-2-imidazolin-2-yl)propane]dihydrochloride, 2,2'-azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride, 2,2'-azobis[2-(4,5,6,7-tetrahydro-1H-1,3-diazepin-2-yl)propane]dihydrochloride, 2,2'-azobis[2-(3,4,5,6-tetrahydropyrimidin-2-yl)propane]dihydrochloride, 2,2'-azobis[2-(5-hydroxy-3,4,5,6-tetrahydropyrimidin -2-yl)propane]dihydrochloride, 2,2'-azobis {2-[1-(2-00090640 v1) - 13 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 hydroxyethy1)-2-imidazolin-2-yl]propaneldihydrochloride, combinations thereof, and the like.
[0034] Initiators can be added in suitable amounts, such as from about 0.1 to about 8 weight percent of the monomers, in embodiments of from about 0.2 to about 5 weight percent of the monomers, in embodiments from about 0.5 to about 4 weight percent of the monomers.
Chain Transfer Agents [0035] In embodiments, chain transfer agents may also be utilized in forming the latex polymer. Suitable chain transfer agents include dodecanethiol, octanethiol, carbon tetrabromide, combinations thereof, and the like, in amounts from about 0.1 to about 10 percent of monomers, in embodiments from about 0.2 to about 5 percent by weight of monomers, and in embodiments from about 0.5 to about 3.5 percent by weight of monomers, to control the molecular weight properties of the latex polymer when emulsion polymerization is conducted in accordance with the present disclosure.
Functional Monomers [0036] In embodiments, it may be advantageous to include a functional monomer when forming the latex polymer and the particles making up the polymer. Suitable functional monomers include monomers having carboxylic acid functionality. Such monomers may be of the following formula (I):

I II II
H2C¨C¨C-0¨FR2¨C-0+R3¨C¨OH
11 n 0 (I) {00090640v1{ - 14 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 where R1 is hydrogen or a methyl group; R2 and R3 are independently selected from alkyl groups containing from about 1 to about 12 carbon atoms or a phenyl group; n is from about 0 to about 20, in embodiments from about 1 to about 10. Examples of such functional monomers include beta carboxyethyl acrylate (0-CEA), poly(2-carboxyethyl) acrylate, 2-carboxyethyl methacrylate, combinations thereof, and the like.
Other functional monomers which may be utilized include, for example, acrylic acid, methacrylic acid and its derivatives, and combinations of the foregoing.
[0037] In embodiments, the functional monomer having carboxylic acid functionality may also contain a small amount of metallic ions, such as sodium, potassium and/or calcium, to achieve better emulsion polymerization results. The metallic ions may be present in an amount from about 0.001 to about 10 percent by weight of the functional monomer having carboxylic acid functionality, in embodiments from about 0.5 to about 5 percent by weight of the functional monomer having carboxylic acid functionality, in embodiments from about 0.75 to about 4 percent by weight of the functional monomer having carboxylic acid functionality.
[0038] Where present, the functional monomer may be added in amounts from about 0.01 to about 10 percent by weight of the total monomers, in embodiments from about 0.05 to about 5 percent by weight of the total monomers, and in embodiments from about 0.1 to about 3 percent by weight of total monomers.
Wax [0039] Wax dispersions may also be added during formation of a latex polymer in an emulsion aggregation synthesis. Suitable waxes include, for example, submicron wax particles in the size range of from about 50 to about 1000 nanometers, in embodiments of {00090640 vl } - 15 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 from about 100 to about 500 nanometers in volume average diameter, suspended in an aqueous phase of water and an ionic surfactant, nonionic surfactant, or combinations thereof. Suitable surfactants include those described above. The ionic surfactant or nonionic surfactant may be present in an amount of from about 0.1 to about 20 percent by weight, and in embodiments of from about 0.5 to about 15 percent by weight of the wax.
[0040] The wax dispersion according to embodiments of the present disclosure may include, for example, a natural vegetable wax, natural animal wax, mineral wax, and/or synthetic wax. Examples of natural vegetable waxes include, for example, carnauba wax, candelilla wax, Japan wax, and bayberry wax. Examples of natural animal waxes include, for example, beeswax, punic wax, lanolin, lac wax, shellac wax, and spermaceti wax.
Mineral waxes include, for example, paraffin wax, microcrystalline wax, montan wax, ozokerite wax, ceresin wax, petrolatum wax, and petroleum wax. Synthetic waxes of the present disclosure include, for example, Fischer-Tropsch wax, acrylate wax, fatty acid amide wax, silicone wax, polytetrafluoroethylene wax, polyethylene wax, polypropylene wax, and combinations thereof.
[0041] Examples of polypropylene and polyethylene waxes include those commercially available from Allied Chemical and Baker Petrolite, wax emulsions available from Michelman Inc. and the Daniels Products Company, EPOLENE N-15 commercially available from Eastman Chemical Products, Inc., VISCOL 550-P, a low weight average molecular weight polypropylene available from Sanyo Kasel K.K., and similar materials.
In embodiments, commercially available polyethylene waxes possess a molecular weight (Mw) of from about 100 to about 5000, and in embodiments of from about 250 to about {00090640 v1) - 16 -' PATENT APPLICATION
Attorney Docket No 20120439CA01-418295 2500, while the commercially available polypropylene waxes have a molecular weight of from about 200 to about 10,000, and in embodiments of from about 400 to about 5000.
[0042] In embodiments, the waxes may be functionalized. Examples of groups added to functionalize waxes include amines, amides, imides, esters, quaternary amines, and/or carboxylic acids. In embodiments, the functionalized waxes may be acrylic polymer emulsions, for example, JONCRYL 74, 89, 130, 537, and 538, all available from Johnson Diversey, Inc, or chlorinated polypropylenes and polyethylenes commercially available from Allied Chemical, Baker Petrolite Corporation and Johnson Diversey, Inc.
[0043] The wax may be present in an amount of from about 0.1 to about 30 percent by weight, and in embodiments from about 2 to about 20 percent by weight of the toner.
Colorants [0044] The latex particles may be added to a colorant dispersion. The colorant dispersion may include, for example, submicron colorant particles having a size of, for example, from about 50 to about 500 nanometers in volume average diameter and, in embodiments, of from about 100 to about 400 nanometers in volume average diameter.
The colorant particles may be suspended in an aqueous water phase containing an anionic surfactant, a nonionic surfactant, or combinations thereof. In embodiments, the surfactant may be ionic and may be from about 1 to about 25 percent by weight, and in embodiments from about 4 to about 15 percent by weight, of the colorant.
[0045] Colorants useful in forming toners in accordance with the present disclosure include pigments, dyes, mixtures of pigments and dyes, mixtures of pigments, mixtures of dyes, and the like. The colorant may be, for example, carbon black, cyan, yellow, magenta, red, orange, brown, green, blue, violet, or combinations thereof. In {00090640v1} - 17 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 embodiments a pigment may be utilized. As used herein, a pigment includes a material that changes the color of light it reflects as the result of selective color absorption. In embodiments, in contrast with a dye which may be generally applied in an aqueous solution, a pigment generally is insoluble. For example, while a dye may be soluble in the carrying vehicle (the binder), a pigment may be insoluble in the carrying vehicle.
[0046] In embodiments wherein the colorant is a pigment, the pigment may be, for example, carbon black, phthalocyanines, quinacridones, red, green, orange, brown, violet, yellow, fluorescent colorants including RHODAMINE BTM type, and the like.
[0047] The colorant may be present in the toner of the disclosure in an amount of from about 1 to about 25 percent by weight of toner, in embodiments in an amount of from about 2 to about 15 percent by weight of the toner.
[0048] Exemplary colorants include carbon black like REGAL 330 magnetites;
Mobay magnetites including M08029TM, MO8O6OTM; Columbian magnetites; MAPICO
BLACKSTM and surface treated magnetites; Pfizer magnetites including CB4799TM, CB5300TM, CB5600TM, MCX6369TM; Bayer magnetites including, BAYFERROX
8600TM, 8610TM; Northern Pigments magnetites including, NP-604TM, NP-608TM;
Magnox magnetites including TMB-100Tm, or TMB-104Tm, HELIOGEN BLUE
L6900TM, D6840TM, D7O8OTM, D7O2OTM, PYLAM OIL BLUETM, PYLAM OIL
YELLOWTM, PIGMENT BLUE 1TM available from Paul Uhlich and Company, Inc.;
PIGMENT VIOLET 1TM, PIGMENT RED 48TM, LEMON CHROME YELLOW DCC
1026TM, E.D. TOLUIDINE REDTM and BON RED CTM available from Dominion Color Corporation, Ltd., Toronto, Ontario; NOVAPERM YELLOW FGLTM, HOSTAPERM
PINK ETM from Hoechst; and CINQUASIA MAGENTATm available from E.I. DuPont {00090640v1} - 18 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 de Nemours and Company. Other colorants include 2,9-dimethyl-substituted quinacridone and anthraquinone dye identified in the Color Index as Cl 60710, Cl Dispersed Red 15, diazo dye identified in the Color Index as Cl 26050, Cl Solvent Red 19, copper tetra(octadecyl sulfonamido) phthalocyanine, x-copper phthalocyanine pigment listed in the Color Index as Cl 74160, Cl Pigment Blue, Anthrathrene Blue identified in the Color Index as Cl 69810, Special Blue X-2137, diarylide yellow 3,3-dichlorobenzidene acetoacetanilides, a monoazo pigment identified in the Color Index as Cl 12700, Cl Solvent Yellow 16, a nitrophenyl amine sulfonamide identified in the Color Index as Foron Yellow SE/GLN, Cl Dispersed Yellow 33, 2,5-dimethoxy-4-sulfonanilide phenylazo-4'-chloro-2,5-dimethoxy acetoacetanilide, Yellow 180 and Permanent Yellow FGL. Organic soluble dyes having a high purity for the purpose of color gamut which may be utilized include Neopen Yellow 075, Neopen Yellow 159, Neopen Orange 252, Neopen Red 336, Neopen Red 335, Neopen Red 366, Neopen Blue 808, Neopen Black X53, Neopen Black X55, wherein the dyes are selected in various suitable amounts, for example from about 0.5 to about 20 percent by weight, in embodiments, from about 5 to about 18 weight percent of the toner.
[0049] In embodiments, colorant examples include Pigment Blue 15:3 having a Color Index Constitution Number of 74160, Magenta Pigment Red 81:3 having a Color Index Constitution Number of 45160:3, Yellow 17 having a Color Index Constitution Number of 21105, and known dyes such as food dyes, yellow, blue, green, red, magenta dyes, and the like.
[0050] In other embodiments, a magenta pigment, Pigment Red 122 (2,9-dimethylquinacridone), Pigment Red 185, Pigment Red 192, Pigment Red 202, Pigment {00090640v1} - 19 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 Red 206, Pigment Red 235, Pigment Red 269, combinations thereof, and the like, may be utilized as the colorant. Pigment Red 122 (sometimes referred to herein as PR-122) has been widely used in the pigmentation of toners, plastics, ink, and coatings, due to its unique magenta shade.
pH adjustment Agent [0051] In some embodiments a pH adjustment agent may be added to control the rate of the emulsion aggregation process. The pH adjustment agent utilized in the processes of the present disclosure can be any acid or base that does not adversely affect the products being produced. Suitable bases can include metal hydroxides, such as sodium hydroxide, potassium hydroxide, ammonium hydroxide, and optionally combinations thereof.
Suitable acids include nitric acid, sulfuric acid, hydrochloric acid, citric acid, acetic acid, and optionally combinations thereof. The amount of the base addition may thus be of from about 0.1 % wt/wt to about 20% wt/wt, in other embodiments from about 0.2%
wt/wt to about 10% wt/wt, in further embodiments from about 0.5% wt/wt to about 5%
wt/wt.
Coagulants [0052] In embodiments, a coagulant may be added during or prior to aggregating the latex and the aqueous colorant dispersion. The coagulant may be added over a period of time from about 1 minute to about 60 minutes, in embodiments from about 1.25 minutes to about 20 minutes, in embodiments from about 2 minutes to about 15 minutes, depending on the processing conditions.
100531 Examples of suitable coagulants include polyaluminum halides such as polyaluminum chloride (PAC), or the corresponding bromide, fluoride, or iodide, {00090640 v1) - 20 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 polyaluminum silicates such as polyaluminum sulfo silicate (PASS), and water soluble metal salts including aluminum chloride, aluminum nitrite, aluminum sulfate, potassium aluminum sulfate, calcium acetate, calcium chloride, calcium nitrite, calcium oxylate, calcium sulfate, magnesium acetate, magnesium nitrate, magnesium sulfate, zinc acetate, zinc nitrate, zinc sulfate, combinations thereof, and the like. One suitable coagulant is PAC, which is commercially available and can be prepared by the controlled hydrolysis of aluminum chloride with sodium hydroxide. Generally, PAC can be prepared by the addition of two moles of a base to one mole of aluminum chloride. The species is soluble and stable when dissolved and stored under acidic conditions if the pH is less than about 5. The species in solution is believed to contain the formula A11304(01-)24(H20)12 with about 7 positive electrical charges per unit.
[0054] In embodiments, suitable coagulants include a polymetal salt such as, for example, polyaluminum chloride (PAC), polyaluminum bromide, or polyaluminum sulfosilicate. The polymetal salt can be in a solution of nitric acid, or other diluted acid solutions such as sulfuric acid, hydrochloric acid, citric acid or acetic acid. The coagulant may be added in amounts from about 0.01 to about 5 percent by weight of the toner, in embodiments from about 0.1 to about 3 percent by weight of the toner, and in embodiments from about 0.5 to about 2 percent by weight of the toner.
Aggregating Agents [0055] Any aggregating agent capable of causing complexation might be used in forming toner of the present disclosure. Both alkali earth metal or transition metal salts can be utilized as aggregating agents. In embodiments, alkali (II) salts can be selected to aggregate sodium sulfonated polyester colloids with a colorant to enable the formation of {00090640v1} - 21 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 a toner composite. Such salts include, for example, beryllium chloride, beryllium bromide, beryllium iodide, beryllium acetate, beryllium sulfate, magnesium chloride, magnesium bromide, magnesium iodide, magnesium acetate, magnesium sulfate, calcium chloride, calcium bromide, calcium iodide, calcium acetate, calcium sulfate, strontium chloride, strontium bromide, strontium iodide, strontium acetate, strontium sulfate, barium chloride, barium bromide, barium iodide, and optionally combinations thereof Examples of transition metal salts or anions which may be utilized as aggregating agent include acetates of vanadium, niobium, tantalum, chromium, molybdenum, tungsten, manganese, iron, ruthenium, cobalt, nickel, copper, zinc, cadmium or silver;
acetoacetates of vanadium, niobium, tantalum, chromium, molybdenum, tungsten, manganese, iron, ruthenium, cobalt, nickel, copper, zinc, cadmium or silver;
sulfates of vanadium, niobium, tantalum, chromium, molybdenum, tungsten, manganese, iron, ruthenium, cobalt, nickel, copper, zinc, cadmium or silver; and aluminum salts such as aluminum acetate, aluminum halides such as polyaluminum chloride, combinations thereof, and the like. The amount of the aggregating agent addition may thus be of from about 0.01 % wt/wt to about 1% wt/wt, in other embodiments from about 0.1%
wt/wt to about 0.5% wt/wt, in further embodiments from about 0.15% wt/wt to about 0.3%
wt/wt.
Reaction Conditions 100561 In the emulsion aggregation process, the reactants may be added to a suitable reactor, such as a mixing vessel. The resulting blend of latex, optionally in a dispersion, CCA, optionally in dispersion, optional colorant dispersion, optional wax, optional coagulant, and optional aggregating agent, may then be stirred and heated to a temperature at or above the glass transition temperature (Tg) of the latex, in embodiments {00090640 v11 - 22 -' PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 from about 30 C to about 70 C, in embodiments of from about 40 C to about 65 C, in embodiments from about 45 C to about 60 C, for a period of time from about 0.2 hours to about 6 hours, in embodiments from about 0.3 hours to about 5 hours, in embodiments from about 0.5 hours to about 3 hours, resulting in toner aggregates of from about 3 microns to about 15 microns in volume average diameter, in embodiments of from about 4 microns to about 8 microns in volume average diameter, in embodiments from about 5 microns to about 7 microns in volume average diameter.
[0057] Once the desired final size of the toner particles is achieved, the pH
of the mixture may be adjusted with a base, to freeze the growth process of the particle, to a value of no higher than 7 or no higher than 4.5. In specific embodiments, the pH is adjusted to from about 3.5 to about 7, or from about 4 to about 6.5. The base may include any suitable base such as, for example, alkali metal hydroxides such as, for example, sodium hydroxide, potassium hydroxide, and ammonium hydroxide. The alkali metal hydroxide may be added in amounts from about 0.1 to about 30 percent by weight of the mixture, in embodiments from about 0.5 to about 15 percent by weight of the mixture.
[0058] The toner particles may be subsequently coalesced. Coalescing may include stirring and heating at a temperature of from about 80 C to about 100 C, in embodiments from about 90 C to about 99 C, for a period of from about 0.5 hours to about 12 hours, and in embodiments from about 1 hour to about 6 hours. Coalescing may be accelerated by additional stirring. The particles are coalesced until the desired circularity or roundness of the particles are reached, for example, from about 0.960 to about 0.990, or from about 0.965 to about 0.975.
{00090640 v1) - 23 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 100591 The pH of the mixture may then be lowered to from about 3.5 to about 6, in embodiments from about 3.7 to about 5.5, with, for example, an acid to coalesce the toner aggregates. Suitable acids include, for example, nitric acid, sulfuric acid, hydrochloric acid, citric acid or acetic acid. The amount of acid added may be from about 0.1 to about 30 percent by weight of the mixture, and in embodiments from about 1 to about percent by weight of the mixture.
[0060] The mixture is cooled in a cooling or freezing step. Cooling may be at a temperature of from about 20 C to about 40 C, in embodiments from about 22 C
to about 30 C over a period time from about 1 hour to about 8 hours, and in embodiments from about 1.5 hours to about 5 hours.
[0061] In embodiments, cooling a coalesced toner slurry includes quenching by adding a cooling medium such as, for example, ice, dry ice and the like, to effect rapid cooling to a temperature of from about 20 C to about 40 C, and in embodiments of from about to about 30 C. Quenching may be feasible for small quantities of toner, such as, for example, less than about 2 liters, in embodiments from about 0.1 liters to about 1.5 liters.
For larger scale processes, such as for example greater than about 10 liters in size, rapid cooling of the toner mixture may not be feasible or practical, neither by the introduction of a cooling medium into the toner mixture, nor by the use of jacketed reactor cooling.
Washing [0062] The toner slurry may then be washed. Washing may be carried out at a pH
of from about 7 to about 12, and in embodiments at a pH of from about 9 to about 11. The washing may be at a temperature of from about 30 C to about 70 C, in embodiments from about 40 C to about 67 C. The washing may include filtering and re-slurrying a {00090640v1} - 24 -, , PATENT APPLICATION
Attorney Docket No 20120439CA01-418295 filter cake including toner particles in deionized water. The filter cake may be washed one or more times by deionized water, or washed by a single deionized water wash at a pH of about 4 wherein the pH of the slurry is adjusted with an acid, and followed optionally by one or more deionized water washes. In embodiments, the particles may be washed about three times with water.
[0063] For example, in embodiments, toner particles may be washed in 40 C
deionized water, filtered, re-slurried with HC1 acid addition, filtered, and re-slurried in fresh deionized water. The washes may continue until the solution conductivity of the filtrate is measured to be low (less than 10 microsiemens per centimeter), which indicates that the ion content is significantly reduced and will not interfere with the metal, in embodiments zinc, treatment.
[0064] The washing o the toner particles with the metal ion solution may take place at a temperature of from about 30 C to about 50 C. The metal ion solution, in embodiments including zinc, is added dropvvise to the slurry in an amount of from about 1 to about 120 drops. The metal ion solution is added dropwise to the slurry at a rate of from about 1 drops/min to about 120 drops/min, in embodiments from about 5 drops/min to about 100 drops/min, in embodiments from about 10 drops/min to about 60 drops/min, and mixed for a period of from about 0.5 hours to about 1.5 hours, in embodiments from about 0.75 hours to about 1.25 hours, in embodiments about 1 hour. During this time of mixing, the slurry is slightly heated from about 20 C to about 60 C, in other embodiments from about 30 C to about 55 C, in further embodiments from about 35 C to about 45 C. The zinc attaches to the toner surface in a controlled manner without aggregating the particles together.
{ 00090640 v 1 } - 25 -' ' PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 [0065] In embodiments, the particles may then be subjected to an additional washing step including a metal in solution to enhance their charging characteristics. An increase in the amount of certain metal based charging agents, in embodiments zinc salicylate or other similar agent, on the surface of a toner particle may increase the charging of the toner particles. Thus, in accordance with the present disclosure, a washing step including such a metal may increase the charging of the toner particles.
Treatment of Coalesced Particles [0066] After coalescing, the process of the present embodiments subject the toner particles one or more additional treatment steps to improve the charging properties of the toner particles. In embodiments, the toner particles are given a final wash, as described above, and re-slurried in water. In embodiments, a toner wet cake may be re-dispersed in water, in embodiments deionized water, and heated to a temperature of from about from about 20 C to about 50 C, in embodiments from about 35 C to about 45 C, in other embodiments about 40 C. A charge control agent dispersion is then added to the slurry.
[0067] The dispersion may comprise a metal-based charging agent, such as for example, zinc salicylate, chromium salicylate, aluminum salicylate or other metal based charge control agents. The dispersion is added thereto and mixed so that the metal salicylate attaches to the surface of the toner particles. Suitable sources of metal charging agents in this step may include zinc acetate, zinc butyrate, zinc chlorate, zinc chloride, zinc bromide, zinc citrate, zinc fluoride, zinc salicylate, aluminum salicylate , zinc fluoride tetrahydrate, zinc 3,5-ditertiarybutylsalicylic acid, aluminum 3,5-ditertiarybutylsalicylic acid combinations thereof, and the like. In accordance with the present disclosure, the dispersion may incorporate any suitable CCA as disclosed herein. In specific {00090640 v1} - 26 -PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 embodiments, a CCA such as 3,5-di-tert-butylsalicylic acid or a mixture of hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoate] and 3,5-di-tert-butylsalicylic acid may be added to improve charging in all zones and the life of the toner.
In embodiments, the charge control total solids in dispersion is added in an amount of from about 0.1 to about 10 percent, or from about 0.5 to about 8 percent, or from about 1 to about 6 percent by weight of CCA, the total weight of the particle batch, including all components that are being mixed together in the reactor. In embodiments, the slurry is solids in the batch comprising from about 10 to about 20% of solids total.
Thus, in embodiments, the charge control solids in the dispersion is added in an amount of from about.05 to about 10 percent, or from about 2.0 to about 5.0 percent by weight of the total solids weight in the slurry.
[0068] The slurry comprising the charge control agent dispersion is next heated to above the Tg of the latex, for example, from about 40 to about 65 C, or from about 45 to about 55 C, and mixed with constant high shearing for up to one hour, for example, from about 2 to about 120 minutes, or from about 20 to about 60 minutes. The slurry is mixed at a speed of from about 1,000 to about 10,000 RPM, or from about 4,000 to about 7,000 RPM.
[0069] The treated toner may then be filtered and redispersed in deionized water, then freeze dried for about 48 hours. The drying may be continued until the moisture level of the particles is of from about 0% to about 1 % by weight, in embodiments from about 0.1% to about 0.7% by weight. The toner particles produced possess a triboelectric charge of from about -2 piC/g to about -60 piC/g, or from about -10 [iC/g to about -45 liC/g, or from about -20 C/g to about -35 11C/g.
{ 00090640 v11 - 27 -Additives [0070] Further optional additives which may be combined with a toner include any additive to enhance the properties of toner compositions. Included are surface additives, color enhancers, etc. Surface additives that can be added to the toner compositions after washing or drying include, for example, metal salts, metal salts of fatty acids, colloidal silicas, metal oxides, strontium titanates, combinations thereof, and the like, which additives are each usually present in an amount of from about 0.1 to about 10 weight percent of the toner, in embodiments from about 0.5 to about 7 weight percent of the toner. Examples of such additives include, for example, those disclosed in U.S. Patent Nos. 3,590,000, 3,720,617, 3,655,374 and 3,983,045.
Other additives include zinc stearate and AEROSIL R972 available from Degussa. The coated silicas of U.S. Patent No. 6,190,815 and U.S. Patent No. 6,004,714 can also be selected in amounts, for example, of from about 0.05 to about 5 percent by weight of the toner, in embodiments from about 0.1 to about 2 percent by weight of the toner.
These additives can be added during the aggregation or blended into the formed toner product.
[0071] Toner particles produced utilizing a latex of the present disclosure may have a size of about 1 micron to about 20 microns, in embodiments about 2 microns to about 15 microns, in embodiments about 3 microns to about 7 microns. Toner particles of the present disclosure may have a circularity of from about 0.9 to about 0.99, in embodiments from about 0.92 to about 0.98.

[0072] Following the methods of the present disclosure, toner particles may be obtained having several advantages compared with conventional toners: (1) increase in the robustness of the particles' triboelectric charging, which reduces toner defects and improves machine performance; (2) easy to implement, no major changes to existing aggregation/coalescence processes; and (3) increase in productivity and reduction in unit manufacturing cost (UMC) by reducing the production time and the need for rework (quality yield improvement).
Uses [0073] Toner in accordance with the present disclosure can be used in a variety of imaging devices including printers, copy machines, and the like. The toners generated in accordance with the present disclosure are excellent for imaging processes, especially xerographic processes and are capable of providing high quality colored images with excellent image resolution, acceptable signal-to-noise ratio, and image uniformity. Further, toners of the present disclosure can be selected for electrophotographic imaging and printing processes such as digital imaging systems and processes.
[0074] Developer compositions can be prepared by mixing the toners obtained with the processes disclosed herein with known carrier particles, including coated carriers, such as steel, ferrites, and the like. Such carriers include those disclosed in U.S.
Patent Nos. 4,937,166 and 4,935,326. The carriers may be present from about 2 percent by weight of the toner to about 8 percent by weight of the toner, in embodiments from about 4 percent by weight to about 6 percent by weight of the toner. The carrier particles can also include a core with a polymer coating thereover, such as polymethylmethacrylate (PMMA), having dispersed therein a conductive component like conductive carbon black. Carrier coatings include silicone resins such as methyl silsesquioxanes, fluoropolymers such as polyvinylidiene fluoride, mixtures of resins not in close proximity in the triboelectric series such as polyvinylidiene fluoride and acrylics, thermosetting resins such as acrylics, combinations thereof and other known components.
[0075] Development may occur via discharge area development. In discharge area development, the photoreceptor is charged and then the areas to be developed are discharged. The development fields and toner charges are such that toner is repelled by the charged areas on the photoreceptor and attracted to the discharged areas. This development process is used in laser scanners.
[0076] Development may be accomplished by the magnetic brush development process disclosed in U.S. Patent No. 2,874,063. This method entails the carrying of a developer material containing toner of the present disclosure and magnetic carrier particles by a magnet. The magnetic field of the magnet causes alignment of the magnetic carriers in a brush like configuration, and this "magnetic brush" is brought into contact with the electrostatic image bearing surface of the photoreceptor. The toner particles are drawn from the brush to the electrostatic image by electrostatic attraction to the discharged areas of the photoreceptor, and development of the image results. In embodiments, the conductive magnetic brush process is used wherein the developer includes conductive carrier particles and is capable of conducting an electric current between the biased magnet through the carrier particles to the photoreceptor.

Imaging 100771 Imaging methods are also envisioned with the toners disclosed herein.
Such methods include, for example, some of the above patents mentioned above and U.S.
Patent Nos. 4,265,990, 4,584,253 and 4,563,408. The imaging process includes the generation of an image in an electronic printing magnetic image character recognition apparatus and thereafter developing the image with a toner composition of the present disclosure. The formation and development of images on the surface of photoconductive materials by electrostatic means is well known. The basic xerographic process involves placing a uniform electrostatic charge on a photoconductive insulating layer, exposing the layer to a light and shadow image to dissipate the charge on the areas of the layer exposed to the light, and developing the resulting latent electrostatic image by depositing on the image a finely-divided electroscopic material, for example, toner. The toner will normally be attracted to those areas of the layer, which retain a charge, thereby forming a toner image corresponding to the latent electrostatic image. This powder image may then be transferred to a support surface such as paper. The transferred image may subsequently be permanently affixed to the support surface by heat. Instead of latent image formation by uniformly charging the photoconductive layer and then exposing the layer to a light and shadow image, one may form the latent image by directly charging the layer in image configuration. Thereafter, the powder image may be fixed to the photoconductive layer, eliminating the powder image transfer. Other suitable fixing means such as solvent or overcoating treatment may be substituted for the foregoing heat fixing step.

[0078] Various exemplary embodiments encompassed herein include a method of imaging which includes generating an electrostatic latent image on an imaging member, developing a latent image, and transferring the developed electrostatic image to a suitable substrate.
[0079] While the description above refers to particular embodiments, it will be understood that many modifications may be made without departing from the scope thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope of embodiments herein.
[0080] The presently disclosed embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, the scope of embodiments being indicated by the appended claims rather than the foregoing description. All changes that come within the meaning of and range of equivalency of the claims are intended to be embraced therein.
EXAMPLES
[0081] The example set forth herein below and is illustrative of different compositions and conditions that can be used in practicing the present embodiments.
All proportions are by weight unless otherwise indicated. It will be apparent, however, that the embodiments can be practiced with many types of compositions and can have many different uses in accordance with the disclosure above and as pointed out hereinafter.
[0082] Example 1 [0083] Formation of Toner Particles 100841 Styrene/Butylacrylate latex polymer was mixed with low melt paraffin wax and carbon black and cyan pigment in the appropriate ratios. Polyaluminum chloride was PATENT APPLICATION
Attorney Docket No. 20120439CA01-418295 then added to the system and the mix homogenized for a period of time. Once homogenized, the reactor contents were heated to near the glass transition temperature of the polymer for a period of time until the particle reached desired size. Once the aggregate was at the appropriate size (6.2 pm), the reactor was held at temperature for a period of time and then a base was added to further freeze the particle size and adjust the PH higher in alkalinity. Once frozen, the particle batch temperature was raised to no less than 90 C and the pH was adjusted to no higher than 5Ø The batch then coalesced for a period of time until a circularity (roundness) of the particle was 0.970 or greater. The batch was then cooled, pH adjusted up, washed then dried. Dried particle was then taken and blended with the optimized additive formulation to produce a toner. This resulted in a homogeneous dispersion of CCA polymer in the particle.
[0085] Table 1 provides the experimental results of the toner particles prepared with and without shell to improve the incorporate of zinc charge control agent and reduce levels of surfactant.
Table 1 Bontron Particle (1CP) Surfactant Amount Toner E-84 (LC) (LC/MS) Parent (XPS) Run Description Bontron Al (tig/g) Zn (pg/g) Dowfax 2A Tayca Zn E-84 (%) (1.tg/g) (11g/g) (attachment %) 1 0% CCA- 0 791 1.2 107 1409 0 latex in shell 2 0% CCA- 0 931 ND 26 510 0 latex in core, no shell 3 20% Zn 0.15 843 113 201 1761 0.11 CCA-latex in shell 4 20% Zn 0.39 872 290 126 1395 0.28 CCA-latex in core, no shell {00090640 v 1 } - 33 -[0086] From Table 1, reduction in surfactant in the particle without shell is observed as well as an increase in total zinc charge control agent in the particle without shell as compared to the particle with shell. Moreover, the particle with 20% zinc charge control with shell showed a reduced total amount of retained zinc charge control agent while the shell-less toner particle showed higher bulk zinc charge control agent and XPS (surface) zinc levels.
[0087] It will be appreciated that various of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. The claims should not be limited by the preferred embodiments described herein but should be afforded the broadest interpretation consistent with the specification as a whole.

Claims (17)

WHAT IS CLAIMED IS:
1. A toner comprising shell-less toner particles comprising a core portion comprising a resin, wax and colorant, and a charge control agent distributed homogenously throughout the core portion, wherein a bulk level of the charge control agent in the core portion is from about 0.1 to about 50 percent by weight of the total weight of the toner particle and a surface level of the charge control agent on the core portion is from about 0.01 to about 10 percent by weight of the total weight of the toner particle.
2. The toner of claim 1, wherein toner is an emulsion aggregation toner.
3. The toner of claim 1, wherein the charge control agent is selected from the group consisting of metal complexes of alkyl derivatives of acids such as salicylic acid, dicarboxylic acid derivatives, benzoic acid, oxynaphthoic acid, and sulfonic acids, or other complexes such as polyhydroxyalkanoate quaternary phosphonium trihalozincate, and metal complexes of dimethyl sulfoxide, and mixtures thereof.
4. The toner of claim 1, wherein the charge control agent is present in an amount of from about 0.01 to about 15 percent by weight of the total weight of the toner particle.
5. The toner of claim 1 having a triboelectric charge of from about -5 to about -60 uC/gm in A zone.
6. The toner of claim 1, wherein the bulk level of the charge control agent is increased from about 5 to about 30 percent as compared to a bulk level of a toner particle prepared with a shell.
7. The toner of claim 1, wherein the surface level of the charge control agent is increased from about 0.1 to about 15 percent as compared to a bulk level of a toner particle prepared with a shell.
8. The toner of claim 1, wherein the toner particles further comprise one or more surface additives.
9. The toner of claim 1, wherein the toner particles have an average particle size of from about 4.5 to about 7.5 µm.
10. A toner comprising shell-less toner particles comprising a core portion comprising a resin, wax and colorant, a charge control agent distributed homogenously throughout the core portion, and a residual surfactant on a surface of the core portion, wherein an amount of surfactant present in the toner particle is from about 20 to about 2500 ppm of the toner particle.
11. The toner of claim 10, wherein the amount of surfactant present in the toner particle is reduced as compared to an amount of surfactant present in a toner particle prepared with a shell.
12. The toner of claim 10, wherein amount of surfactant present in the toner particle is decreased from about 80 percent to about 30 percent as compared to an amount of surfactant present in a toner particle prepared with a shell.
13. A process for producing toner comprising:
adding and mixing a colorant, a wax, and a charge control agent to an emulsion comprising at least one resin to form toner particles;
aggregating the particles to form aggregated particles; and coalescing the aggregated particles to form shell-less toner particles comprising a core portion comprising a resin, wax and colorant, and a charge control agent distributed homogeneously throughout the core portion, wherein a bulk level of the charge control agent in the core portion is from about 0.1 to about 50 percent by weight of the total weight of the toner particle and a surface level of the charge control agent on the core portion is from about 0.01 to about 10 percent by weight of the total weight of the toner particle.
14. The process of claim 13 further comprising washing the shell-less toner particles.
15. The process of claim 13, wherein toner is an emulsion aggregation toner.
16. The process of claim 13, wherein the charge control agent is selected from the group consisting of a zinc complex of 3,5-di-tert-butylsalicylic acid in powder form, a mixture of hydroxyaluminium-bis[2-hydroxy-3,5-di-tert-butylbenzoate]
and 3,5-di-tert-butylsalicylic acid, a calcium complex of 3,5-di-tert-butylsalicylic acid, a zirconium complex of 3,5-di-tert-butylsalicylic acid, an aluminum complex of 3,5-di-tert-butylsalicylic acid, mixtures thereof.
17. The process of claim 13, wherein the toner has a triboelectric charge of from about -5 to about -60 uC/gm.
CA2831889A 2012-11-01 2013-10-30 Toner compositions Active CA2831889C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/666,856 US8778582B2 (en) 2012-11-01 2012-11-01 Toner compositions
US13/666,856 2012-11-01

Publications (2)

Publication Number Publication Date
CA2831889A1 CA2831889A1 (en) 2014-05-01
CA2831889C true CA2831889C (en) 2016-07-19

Family

ID=50547542

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2831889A Active CA2831889C (en) 2012-11-01 2013-10-30 Toner compositions

Country Status (4)

Country Link
US (1) US8778582B2 (en)
JP (1) JP2014092785A (en)
BR (1) BR102013028098A2 (en)
CA (1) CA2831889C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10126678B2 (en) * 2015-10-20 2018-11-13 Ricoh Company, Ltd. Toner, toner housing unit, image forming apparatus, and image forming method

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874063A (en) 1953-03-23 1959-02-17 Rca Corp Electrostatic printing
US3590000A (en) 1967-06-05 1971-06-29 Xerox Corp Solid developer for latent electrostatic images
US3720617A (en) 1970-05-20 1973-03-13 Xerox Corp An electrostatic developer containing modified silicon dioxide particles
US3983045A (en) 1971-10-12 1976-09-28 Xerox Corporation Three component developer composition
US4265990A (en) 1977-05-04 1981-05-05 Xerox Corporation Imaging system with a diamine charge transport material in a polycarbonate resin
US4584253A (en) 1984-12-24 1986-04-22 Xerox Corporation Electrophotographic imaging system
US4563408A (en) 1984-12-24 1986-01-07 Xerox Corporation Photoconductive imaging member with hydroxyaromatic antioxidant
US4935326A (en) 1985-10-30 1990-06-19 Xerox Corporation Electrophotographic carrier particles coated with polymer mixture
US4937166A (en) 1985-10-30 1990-06-26 Xerox Corporation Polymer coated carrier particles for electrophotographic developers
US5223368A (en) 1991-09-06 1993-06-29 Xerox Corporation Toner and developer compositions comprising aluminum charge control agent
US5227460A (en) 1991-12-30 1993-07-13 Xerox Corporation Cross-linked toner resins
US5346797A (en) 1993-02-25 1994-09-13 Xerox Corporation Toner processes
US5403693A (en) 1993-06-25 1995-04-04 Xerox Corporation Toner aggregation and coalescence processes
US5418108A (en) 1993-06-25 1995-05-23 Xerox Corporation Toner emulsion aggregation process
US5364729A (en) 1993-06-25 1994-11-15 Xerox Corporation Toner aggregation processes
US5501935A (en) 1995-01-17 1996-03-26 Xerox Corporation Toner aggregation processes
US5527658A (en) 1995-03-13 1996-06-18 Xerox Corporation Toner aggregation processes using water insoluble transition metal containing powder
US5585215A (en) 1996-06-13 1996-12-17 Xerox Corporation Toner compositions
JP3577390B2 (en) * 1996-07-03 2004-10-13 コニカミノルタビジネステクノロジーズ株式会社 Electrostatic latent image developing toner and method of manufacturing the same
US5650255A (en) 1996-09-03 1997-07-22 Xerox Corporation Low shear toner aggregation processes
US5650256A (en) 1996-10-02 1997-07-22 Xerox Corporation Toner processes
US5916725A (en) * 1998-01-13 1999-06-29 Xerox Corporation Surfactant free toner processes
US6004714A (en) 1998-08-11 1999-12-21 Xerox Corporation Toner compositions
US6190815B1 (en) 1998-08-11 2001-02-20 Xerox Corporation Toner compositions
US6165668A (en) 1999-12-15 2000-12-26 Eastman Kodak Company N-[2-(1,2-benzisothiazol-3(2H)-ylidene 1,1-dioxide)-2-cyanoacetyl]benzenesulfonamide charge control agents for electrostatographic toners and developers
US6221550B1 (en) 2000-03-31 2001-04-24 Nexpress Solutions Llc 4H-pyran charge control agents for electrostatographic toners and developers
US6652634B1 (en) 2001-08-03 2003-11-25 Lexmark International, Inc. Polymeric dispersants used for aqueous pigmented inks for ink-jet printing
KR100457524B1 (en) 2002-06-15 2004-11-17 삼성전자주식회사 Liquid composition for developing latent electrostatic images and method for preparing the same
ES2239290T3 (en) 2002-07-19 2005-09-16 Ricoh Company Ltd. VIRADOR UNDERSTANDING ORGANOMETALIC LOAD CONTROL AGENT BASED ON ZIRCONY AND IMAGE FORMAT METHOD.
US7094513B2 (en) 2002-12-06 2006-08-22 Orient Chemical Industries, Ltd. Charge control agent and toner for electrostatic image development
JP4466485B2 (en) * 2005-06-20 2010-05-26 藤倉化成株式会社 Method for producing negative charge control agent dispersion and method for producing toner for developing negatively chargeable electrostatic latent image
JP4763355B2 (en) * 2005-06-20 2011-08-31 藤倉化成株式会社 Method for producing toner for developing negatively charged electrostatic latent image
JP2008225094A (en) * 2007-03-13 2008-09-25 Nippon Zeon Co Ltd Toner for electrostatic charge image development
CN100483263C (en) * 2007-04-19 2009-04-29 湖北鼎龙化学股份有限公司 Electric charge regulator and carbon powder
GB0708614D0 (en) * 2007-05-04 2007-06-13 Fujifilm Imaging Colorants Ltd Toner, process for making toner and use of toner
GB0708613D0 (en) * 2007-05-04 2007-06-13 Fujifilm Imaging Colorants Ltd Toner, process for making toner and use of toner
US7695884B2 (en) 2007-08-15 2010-04-13 Xerox Corporation Toner compositions and processes
US8715897B2 (en) * 2009-11-16 2014-05-06 Xerox Corporation Toner compositions

Also Published As

Publication number Publication date
JP2014092785A (en) 2014-05-19
BR102013028098A2 (en) 2014-10-29
US20140120467A1 (en) 2014-05-01
CA2831889A1 (en) 2014-05-01
US8778582B2 (en) 2014-07-15

Similar Documents

Publication Publication Date Title
US7943283B2 (en) Toner compositions
EP1898264A2 (en) Toner compositions
US8101328B2 (en) Charge control agents for toner compositions
CA2716666A1 (en) Toner compositions
CA2716695C (en) Toner compositions
CA2746193C (en) Continuous process for producing toner using an oscillatory flow continuous reactor
US7553601B2 (en) Toner compositions
CA2786196C (en) Toner compositions
CA2612962C (en) Toner compositions
EP2034366B1 (en) Toner compositions
US20170031254A1 (en) Toner Compositions
US8778584B2 (en) Toner compositions
US7833684B2 (en) Toner compositions
US8221953B2 (en) Emulsion aggregation process
US8785102B2 (en) Toner compositions
CA2831889C (en) Toner compositions
CA2632339C (en) Toner compositions
US8900787B2 (en) Toner compositions
US20080299479A1 (en) Toner compositions